Necrotizing pancreatitis, microangiopathic hemolytic anemia and thrombocytopenia following the second dose of Pfizer/BioNTech COVID-19 mRNA vaccine

Implementing vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a major asset in slowing down the coronavirus disease 2019 (COVID-19) pandemic. For mRNA vaccines, the main severe adverse events reported in pharmacovigilance systems and post-authorization studies were an...

Descripción completa

Detalles Bibliográficos
Autores principales: Stöllberger, Claudia, Kastrati, Kastriot, Dejaco, Clemens, Scharitzer, Martina, Finsterer, Josef, Bugingo, Patrick, Melichart-Kotik, Madeleine, Wilfing, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2023
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243681/
https://www.ncbi.nlm.nih.gov/pubmed/37280395
http://dx.doi.org/10.1007/s00508-023-02225-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10243681/
https://www.ncbi.nlm.nih.gov/pubmed/37280395
http://dx.doi.org/10.1007/s00508-023-02225-0

Ejemplares similares